تداخل‌های دارویی
Insulin degludec + Metformin-pioglitazone
شدت: شدید
Insulin degludec and Metformin-pioglitazone: major interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Pioglitazone combined with insulin increases the risk of fluid retention, edema and heart failure, and the glucose-lowering effects are additive so hypoglycemia can occur. Metformin adds to the glucose-lowering effect.
معنای این تداخل به زبان ساده
Insulin degludec and Metformin-pioglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Insulin degludec belongs to Endocrine; Metformin-pioglitazone belongs to Endocrine.
چرا رخ می‌دهد
Additive glucose lowering, with insulin and PPAR-gamma agonism both promoting sodium and fluid retention.
اقدام لازم
Monitor weight, edema and signs of heart failure, and reduce the insulin dose if hypoglycemia occurs. Avoid in patients with symptomatic heart failure.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Insulin degludec و Metformin-pioglitazone، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Metformin-pioglitazone
تداخلات دیگر Insulin degludec
پرسش‌های متداول
Can I take Insulin degludec with Metformin-pioglitazone?
MediHelp rates the interaction as major. Insulin degludec and Metformin-pioglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pioglitazone combined with insulin increases the risk of fluid retention, edema and heart failure, and the glucose-lowering effects are additive so hypoglycemia can occur. Metformin adds to the glucose-lowering effect.
How serious is the interaction between Insulin degludec and Metformin-pioglitazone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor weight, edema and signs of heart failure, and reduce the insulin dose if hypoglycemia occurs. Avoid in patients with symptomatic heart failure.
What other medicines interact with Metformin-pioglitazone?
MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
